prognostic signature for flt3-like wild type aml
Published 8 months ago • 104 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
3:03
prognostic impact of flt3-itd in older patients with aml
-
1:49
the prognostic value of flt3-itd residual disease in aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
3:21
the prognostic impact of flt3-itd and flt3-tkd in npm1-mutated aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
0:58
flt3 mutation clearance rate in patients with newly diagnosed aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
15:28
progress report iii - jimin lee
-
49:09
digital pathology implementation: go all-in or start small? leif honda ft. trimetis life sciences"
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
1:39
the significance of flt3 mutations in aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:30
triplet combinations in flt3-mutated aml
-
2:40
an overview of the safety profile of flt3 inhibitors in aml
-
2:15
real-world analysis of gilteritinib for r/r flt3-mutated aml
-
6:47
the 2021 treatment algorithm for flt3-mutated aml
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib
-
1:52
the management of r/r flt3-mutated aml
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial